TABLE 4.
Multivariate analysis of the predictors of urine retention post COVID‐19 infection
| Parameter | OR | 95% CI | P |
|---|---|---|---|
| Age | 0.092 | 0.196‐1.096 | .05 |
| IPSS before COVID‐19 | 1.930 | 1.031‐6.893 | <.001 |
| DM | −1.214 | 0.297‐3.451 | .725 |
| Hematuria (microscopic) | 2.086 | 1.373‐8.055 | .129 |
| Monotherapy (alpha‐blockers) | 11.277 | 7918.190 | .999 |
| DRE | 3.677 | 2.311‐39.544 | .111 |
| Urine culture (positive) | 0.686 | 0.504‐0.950 | .01 |
| Constant | −87.125 | 15 836.398 | .996 |
Abbreviations: COVID‐19, coronavirus disease 2019; DM, diabetes mellitus; DRE, digital rectal examination; IPSS, International Prostate Symptom Score; OR, odds ratio.